Randomization Sample Clauses
The Randomization clause establishes the process by which participants or subjects are assigned to different groups or treatments in a study or trial, typically using a random method. This clause outlines the procedures for generating random assignments, such as using computer-generated sequences or random number tables, and may specify who is responsible for implementing the randomization and how allocation concealment is maintained. Its core practical function is to minimize selection bias and ensure that the groups being compared are similar at the outset, thereby enhancing the validity and reliability of the study's results.
Randomization. The Manufacturing Computer shall utilize randomizing procedures in the creation of the Subsets. The randomizing procedures shall be in accordance with Section 6 of this Appendix.
Randomization. Each work period, the random lists shall be compiled by placing each eligible employee’s name into a selection device. Once all names have been deposited, they shall be mixed. After mixing is complete, each name shall be selected one at a time by the Superintendent or his designee. The first name selected shall be placed on the top of the work assignment list, and so forth.
Randomization. Long-term effectiveness of computer-generated tailored patient education 1 month 12 months 1 month Randomization Chapter 5 Recruitment Long-term effectiveness of computer-generated tailored patient education 63 The tailored intervention
Randomization. We want to ensure that even Professionals who have only been active on the Platform for a short time and therefore have a lower chance of scoring on the other ranking parameters have a chance of getting the Job. For example, we allow a Professional who has been active on the Platform for two months or less to be ranked higher than they otherwise would be based on our ranking parameters and this is a purely random selection of the Professional and the place that they appear except for them appearing higher than they otherwise might be. These new Professionals will also be ranked according to the main parameters mentioned above.
Randomization. This is an open-label, non-randomized study.
Randomization. Subjects will be randomized to receive either standard of care (SOC) treatment (no topical therapy for 24 hours post fractional RF treatment) or a topical adjuvant combination treatment utilizing SCR Complex™ and Bio Cel™. The order of treatment will be assigned to subjects through subject number. All subjects will resume skin care as per VenusSkin protocol 24 hours post fractional RF treatments.
Randomization. The PI and/or a member of the research team will review medical records and results of OGTT prior to randomization to exclude subjects with contraindications (see eligibility criteria: section IV.B.2). Eligible patients will be randomized into a lifestyle intervention or a standard of care group. A blocked randomization will be based on body weight – overweight (BMI 25-<30 kg/m2) and obese (BMI > 30 kg/m2), using the randomly permuted blocks method in a set of 4 sequential enrolled patients per group.
Randomization. A complete randomization scheme will be applied with a 1 levosimendan : 1 placebo allocation ratio. The complete randomization scheme will eliminate the possible bias due to predictability of treatment assignment.58
Randomization. Patients will be randomized to the control and study group at the time consent to participate in the study is received. Patients will either be randomized to the MIRI-TL group (MIRI) or the Standard culture group (SC). Randomization means that you will be assigned to a group by chance, like flipping a coin. Neither you, nor your study doctor can choose which group you will be in. You have a 3 in 5 chance of being assigned to the MIRI-TL group and a 2 in 5 chance of being assigned to the Standard Culture group. Following randomization and standard ovarian stimulation protocols to obtain a sufficient number of mature (MII) oocytes, these oocytes will be fertilized by Intra-Cytoplasmic Sperm Injection (ICSI). If a patient has been randomized to the study group, all inseminated oocytes and subsequently all fertilized diploid (2PN) zygotes will be placed in the CultureCoin and then into the MIRI-TL Time-lapse incubator and cultured as per normal protocol to the blastocyst stage (Day 5/6 or 7). Top quality blastocyst(s) will be transferred and monitored for implantation, pregnancy and ongoing birth. Embryo transfers will either occur in a fresh or frozen embryo transfer cycle. • After embryo transfer, your follow-up visits will take place according to the normal schedule for your clinic and as determined by your doctor. • About 12-18 days after the egg retrieval, you will have your blood drawn for a standard pregnancy test. o If the result is negative, your participation in the study will be complete. o If the test result is positive, you will have an ultrasound examination between 5-8 weeks gestational age to evaluate if a clinical pregnancy has been achieved. ▪ If the result is negative, your participation in the study will be complete. • At between 8-12 weeks gestational age, you will have a second ultrasound examination to verify if your pregnancy is ongoing. o If the result is negative, your participation in the study will be complete. o If the test result is positive, you will be followed up until the final outcome of your pregnancy. • Finally, you will be followed up until your pregnancy concludes with delivery of your baby, or pregnancy termination. o Your study participation will be complete after your pregnancy is concluded.